technical paper

ENDO 2020

June 10, 2020

Virtual, United States

The Effects of Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, on Adrenal Androgens and Precursors in Patients with Classic Congenital Adrenal Hyperplasia: Results from A Multiple-Dose Phase 2 Study

Please log in to leave a comment


Transcript English (automatic)

Next from ENDO 2020

technical paper

When the Glucocorticoid Receptor Meets the Mineralocorticoid Receptor in the Nucleus of Human Cells

ENDO 2020

Maria G. Petrillo and 3 other authors

10 June 2020

Similar lecture

technical paper

Transition of Care for Transgender Youth

ENDO 2021

21 March 2021

Stay up to date with the latest Underline news!


  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved